Australia markets close in 2 hours 31 minutes
  • ALL ORDS

    7,328.70
    +22.70 (+0.31%)
     
  • ASX 200

    7,085.20
    +23.50 (+0.33%)
     
  • AUD/USD

    0.7780
    -0.0005 (-0.06%)
     
  • OIL

    65.05
    +0.34 (+0.53%)
     
  • GOLD

    1,822.20
    +6.50 (+0.36%)
     
  • BTC-AUD

    71,669.07
    -1,918.34 (-2.61%)
     
  • CMC Crypto 200

    1,446.99
    -24.42 (-1.66%)
     
  • AUD/EUR

    0.6444
    -0.0005 (-0.07%)
     
  • AUD/NZD

    1.0751
    -0.0005 (-0.04%)
     
  • NZX 50

    12,718.37
    -33.30 (-0.26%)
     
  • NASDAQ

    13,613.73
    +110.36 (+0.82%)
     
  • FTSE

    7,076.17
    +36.87 (+0.52%)
     
  • Dow Jones

    34,548.53
    +318.19 (+0.93%)
     
  • DAX

    15,196.74
    +25.96 (+0.17%)
     
  • Hang Seng

    28,809.58
    +172.12 (+0.60%)
     
  • NIKKEI 225

    29,414.00
    +82.63 (+0.28%)
     

Global Transcatheter Pulmonary Valves Market to Reach $58.6 Million by 2027

ReportLinker
·26-min read

Abstract: - Global Transcatheter Pulmonary Valves Market to Reach $58. 6 Million by 2027. - Amid the COVID-19 crisis, the global market for Transcatheter Pulmonary Valves estimated at US$39.

New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Transcatheter Pulmonary Valves Industry" - https://www.reportlinker.com/p06033159/?utm_source=GNW
8 Million in the year 2020, is projected to reach a revised size of US$58.6 Million by 2027, growing at aCAGR of 5.7% over the period 2020-2027. Balloon-Expanded, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$36.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Self-Expanded segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $10.7 Million, While China is Forecast to Grow at 9.2% CAGR
- The Transcatheter Pulmonary Valves market in the U.S. is estimated at US$10.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.8 Million by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

- Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation

  • Braile Biomedica

  • Colibri Heart Valve LLC

  • Cryolife Inc.

  • Direct Flow Medical Inc.

  • Edward Lifesciences Corporation

  • Jenavalve Technology Inc.

  • Livanova plc

  • Medtronic

  • St. Jude Medical

  • Venus Medtech




Read the full report: https://www.reportlinker.com/p06033159/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Transcatheter
Pulmonary Valves by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Transcatheter Pulmonary
Valves by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Transcatheter Pulmonary
Valves by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Balloon-Expanded
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 5: World Historic Review for Balloon-Expanded by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 6: World 15-Year Perspective for Balloon-Expanded by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Self-Expanded by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 8: World Historic Review for Self-Expanded by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Self-Expanded by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Tissue Engineered
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 11: World Historic Review for Tissue Engineered by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 12: World 15-Year Perspective for Tissue Engineered by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Synthetic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 14: World Historic Review for Synthetic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Synthetic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Adult by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 17: World Historic Review for Adult by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Adult by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Pediatric by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 20: World Historic Review for Pediatric by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Pediatric by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 22: USA Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 24: USA 15-Year Perspective for Transcatheter Pulmonary
Valves by Technology - Percentage Breakdown of Value Sales for
Balloon-Expanded and Self-Expanded for the Years 2012, 2020 &
2027

Table 25: USA Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Transcatheter Pulmonary
Valves by Material Type - Percentage Breakdown of Value Sales
for Tissue Engineered and Synthetic for the Years 2012, 2020 &
2027

Table 28: USA Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 29: USA Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 30: USA 15-Year Perspective for Transcatheter Pulmonary
Valves by End-Use - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2012, 2020 & 2027

CANADA
Table 31: Canada Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 34: Canada Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 38: Canada Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 39: Canada 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Transcatheter Pulmonary
Valves by Technology - Percentage Breakdown of Value Sales for
Balloon-Expanded and Self-Expanded for the Years 2012, 2020 &
2027

Table 43: Japan Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Transcatheter Pulmonary
Valves by Material Type - Percentage Breakdown of Value Sales
for Tissue Engineered and Synthetic for the Years 2012, 2020 &
2027

Table 46: Japan Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 47: Japan Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 48: Japan 15-Year Perspective for Transcatheter Pulmonary
Valves by End-Use - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2012, 2020 & 2027

CHINA
Table 49: China Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Transcatheter Pulmonary
Valves by Technology - Percentage Breakdown of Value Sales for
Balloon-Expanded and Self-Expanded for the Years 2012, 2020 &
2027

Table 52: China Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 53: China Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Transcatheter Pulmonary
Valves by Material Type - Percentage Breakdown of Value Sales
for Tissue Engineered and Synthetic for the Years 2012, 2020 &
2027

Table 55: China Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 56: China Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 57: China 15-Year Perspective for Transcatheter Pulmonary
Valves by End-Use - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2012, 2020 & 2027

EUROPE
Table 58: Europe Current & Future Analysis for Transcatheter
Pulmonary Valves by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 59: Europe Historic Review for Transcatheter Pulmonary
Valves by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 68: Europe Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 69: Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

FRANCE
Table 70: France Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 71: France Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 72: France 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 73: France Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 76: France Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 77: France Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 78: France 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

GERMANY
Table 79: Germany Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 80: Germany Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 81: Germany 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 82: Germany Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 84: Germany 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 85: Germany Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 86: Germany Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 87: Germany 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

ITALY
Table 88: Italy Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 89: Italy Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 90: Italy 15-Year Perspective for Transcatheter Pulmonary
Valves by Technology - Percentage Breakdown of Value Sales for
Balloon-Expanded and Self-Expanded for the Years 2012, 2020 &
2027

Table 91: Italy Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 92: Italy Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 93: Italy 15-Year Perspective for Transcatheter Pulmonary
Valves by Material Type - Percentage Breakdown of Value Sales
for Tissue Engineered and Synthetic for the Years 2012, 2020 &
2027

Table 94: Italy Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 95: Italy Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 96: Italy 15-Year Perspective for Transcatheter Pulmonary
Valves by End-Use - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 97: UK Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 98: UK Historic Review for Transcatheter Pulmonary Valves
by Technology - Balloon-Expanded and Self-Expanded Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 99: UK 15-Year Perspective for Transcatheter Pulmonary
Valves by Technology - Percentage Breakdown of Value Sales for
Balloon-Expanded and Self-Expanded for the Years 2012, 2020 &
2027

Table 100: UK Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 101: UK Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 102: UK 15-Year Perspective for Transcatheter Pulmonary
Valves by Material Type - Percentage Breakdown of Value Sales
for Tissue Engineered and Synthetic for the Years 2012, 2020 &
2027

Table 103: UK Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 104: UK Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 105: UK 15-Year Perspective for Transcatheter Pulmonary
Valves by End-Use - Percentage Breakdown of Value Sales for
Adult and Pediatric for the Years 2012, 2020 & 2027

SPAIN
Table 106: Spain Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 107: Spain Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 108: Spain 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 109: Spain Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 110: Spain Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 111: Spain 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 112: Spain Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 113: Spain Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 114: Spain 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

RUSSIA
Table 115: Russia Current & Future Analysis for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR

Table 116: Russia Historic Review for Transcatheter Pulmonary
Valves by Technology - Balloon-Expanded and Self-Expanded
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 117: Russia 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 118: Russia Current & Future Analysis for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 119: Russia Historic Review for Transcatheter Pulmonary
Valves by Material Type - Tissue Engineered and Synthetic
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 120: Russia 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 121: Russia Current & Future Analysis for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 122: Russia Historic Review for Transcatheter Pulmonary
Valves by End-Use - Adult and Pediatric Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 123: Russia 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 124: Rest of Europe Current & Future Analysis for
Transcatheter Pulmonary Valves by Technology - Balloon-Expanded
and Self-Expanded - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 126: Rest of Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 127: Rest of Europe Current & Future Analysis for
Transcatheter Pulmonary Valves by Material Type - Tissue
Engineered and Synthetic - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Europe Historic Review for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 129: Rest of Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 130: Rest of Europe Current & Future Analysis for
Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027 and % CAGR

Table 131: Rest of Europe Historic Review for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 132: Rest of Europe 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 133: Asia-Pacific Current & Future Analysis for
Transcatheter Pulmonary Valves by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 134: Asia-Pacific Historic Review for Transcatheter
Pulmonary Valves by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 135: Asia-Pacific 15-Year Perspective for Transcatheter
Pulmonary Valves by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 136: Asia-Pacific Current & Future Analysis for
Transcatheter Pulmonary Valves by Technology - Balloon-Expanded
and Self-Expanded - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027 and % CAGR

Table 137: Asia-Pacific Historic Review for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 138: Asia-Pacific 15-Year Perspective for Transcatheter
Pulmonary Valves by Technology - Percentage Breakdown of Value
Sales for Balloon-Expanded and Self-Expanded for the Years
2012, 2020 & 2027

Table 139: Asia-Pacific Current & Future Analysis for
Transcatheter Pulmonary Valves by Material Type - Tissue
Engineered and Synthetic - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 140: Asia-Pacific Historic Review for Transcatheter
Pulmonary Valves by Material Type - Tissue Engineered and
Synthetic Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 141: Asia-Pacific 15-Year Perspective for Transcatheter
Pulmonary Valves by Material Type - Percentage Breakdown of
Value Sales for Tissue Engineered and Synthetic for the Years
2012, 2020 & 2027

Table 142: Asia-Pacific Current & Future Analysis for
Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric -
Independent Analysis of Annual Sales in US$ for the Years
2020 through 2027 and % CAGR

Table 143: Asia-Pacific Historic Review for Transcatheter
Pulmonary Valves by End-Use - Adult and Pediatric Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 144: Asia-Pacific 15-Year Perspective for Transcatheter
Pulmonary Valves by End-Use - Percentage Breakdown of Value
Sales for Adult and Pediatric for the Years 2012, 2020 & 2027

AUSTRALIA
Table 145: Australia Current & Future Analysis for
Transcatheter Pulmonary Valves by Technology - Balloon-Expanded
and Self-Expanded - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027 and % CAGR

Table 146: Australia Historic Review for Transcatheter
Pulmonary Valves by Technology - Balloon-Expanded and
Self-Expanded Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 147: Australia 15-Year Perspective for Transcatheter

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033159/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001